bullish

# 33 India Insight: Paytm Collaborates with Axis, Gland Pharma Approval, Tata Consumer Right Issue

225 Views24 Jul 2024 20:05
​Paytm and Axis Bank team up for improved POS solutions, Gland Pharma and Zydus Lifesciences receive USFDA nods, Tata Consumer plans Rs 3,000 crore rights issue for financial boost.
What is covered in the Full Insight:
  • Paytm and Axis Bank Collaboration
  • Gland Pharma and Zydus Lifesciences USFDA Approvals
  • Tata Consumer Rights Issue
  • India's Aircraft and Ship Leasing Initiative
  • SpiceJet's Fundraising Efforts
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x